Free Trial

Cyclacel Pharmaceuticals (CYCC) Institutional Ownership

Cyclacel Pharmaceuticals logo
$0.23 -0.02 (-7.62%)
As of 10:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)

Current
Institutional Ownership
Percentage
23.58%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$6.55M
Number of
Institutional Sellers
(last 12 months)
0
Get CYCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CYCC Institutional Buying and Selling by Quarter

Cyclacel Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025Armistice Capital LLC1,269,485$354K0.0%+118.7%0.612%
8/15/2024Armistice Capital LLC134,000$217K0.0%N/A9.178%
5/10/2024Acadian Asset Management LLC14,285$29K0.0%-41.0%1.084%
11/1/2022Kestra Advisory Services LLC23,000$34K0.0%N/A0.183%
10/25/2022Raymond James Financial Services Advisors Inc.20,806$30K0.0%-32.5%0.166%
10/18/2022McIlrath & Eck LLC26,342$38K0.0%N/A0.210%
8/15/2022Sio Capital Management LLC454,355$491K0.2%+7.5%4.546%
2/10/2022Acadian Asset Management LLC23,242$89K0.0%N/A0.233%
11/16/2021Two Sigma Advisers LP121,500$640K0.0%+929.7%1.316%
11/15/2021Pura Vida Investments LLC105,141$554K0.0%-33.2%1.139%
11/15/2021Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663%
11/12/2021Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332%
11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108%
10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160%
8/18/2021Ikarian Capital LLC100,000$593K0.0%-66.7%1.083%
8/17/2021Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114%
8/17/2021Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716%
8/16/2021Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393%
8/16/2021Schonfeld Strategic Advisors LLC102,525$607K0.0%-25.0%1.110%
8/16/2021Maven Securities LTD234,500$1.43M0.1%-6.2%2.540%
8/13/2021Northern Trust Corp14,957$89K0.0%N/A0.162%
8/13/2021Geode Capital Management LLC50,860$301K0.0%+143.3%0.551%
8/13/2021Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548%
7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094%
5/19/2021Virtu Financial LLC13,108$93K0.0%+27.3%0.142%
5/19/2021Squarepoint Ops LLC23,836$169K0.0%N/A0.258%
5/18/2021Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491%
5/18/2021Verition Fund Management LLC116,674$830K0.0%N/A1.264%
5/18/2021Morgan Stanley100,000$711K0.0%-13.0%1.083%
5/18/2021Citadel Advisors LLC293,867$2.09M0.0%N/A3.182%
5/18/2021Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707%
5/17/2021Schonfeld Strategic Advisors LLC136,725$972K0.0%N/A1.481%
5/17/2021Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505%
5/17/2021Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249%
5/12/2021Geode Capital Management LLC20,904$148K0.0%N/A0.226%
(Data available from 1/1/2016 forward)

CYCC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CYCC shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals shares: Armistice Capital LLC ($354K), Acadian Asset Management LLC ($29K).Learn more on Cyclacel Pharmaceuticals' institutional investors.

What percentage of Cyclacel Pharmaceuticals' stock is owned by institutional investors?

23.58% of Cyclacel Pharmaceuticals' stock is owned by institutional investors. Learn more on CYCC's institutional investor holdings.

Which institutional investors have been buying Cyclacel Pharmaceuticals' stock?

The following institutional investors have purchased Cyclacel Pharmaceuticals' stock in the last 24 months: Armistice Capital LLC ($823.02K).

How much institutional buying is happening at Cyclacel Pharmaceuticals?

Institutional investors have bought a total of 823,024 shares in the last 24 months. This purchase volume represents approximately $6.55M in transactions.



This page (NASDAQ:CYCC) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners